TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Insmed Inc (INSM)

Healthcare Biotechnology
98.50 $
-0.2% vs. previous close
Closing price · As of: 3. Aug 2026

Insmed Inc (INSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 606 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement INSM
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
12 0.0 0.0 0.0 9.8 136 164 188 245 305 364 606
34 2.0 2.4 2.9 2.4 24 40 44 55 66 86 125
-22 -2.0 -2.4 -2.9 7.4 112 125 144 190 240 278 482
56 74 123 110 145 132 181 273 398 571 598 771
31 43 51 79 168 211 204 234 266 345 461 701
87 117 173 189 315 348 390 519 648 949 1,156 1,658
-87 -117 -173 -189 -307 -235 -265 -375 -457 -710 -878 -1,177
2.4 2.9 3.5 5.9 25 28 30 40 26 82 85 84
-90 -120 -176 -193 -324 -254 -293 -436 -480 -747 -910 -1,272
-10 -2.0 0.1 -0.3 0.2 0.8 1.4 -1.8 1.4 2.6 3.7 5.0
-79 -118 -176 -193 -324 -254 -294 -435 -482 -750 -914 -1,277
-86 -115 -170 -184 -295 -217 -250 -384 -447 -660 -819 -1,172

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?